Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ABT 719

Known as: ABT-719, ABT719 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Recent early clinical drug development for acute kidney injury
ABSTRACT Introduction: Despite significant need and historical trials, there are no effective drugs in use for the prevention or… Expand
2016
2016
ABT‐719 for the Prevention of Acute Kidney Injury in Patients Undergoing High‐Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial
Background Patients undergoing cardiac surgeries with cardiopulmonary bypass (on‐pump) have a high risk for acute kidney injury… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Highly Cited
1999
Highly Cited
1999
Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 position.
  • Z. Ma, D. Chu, +9 authors Y. Or
  • Journal of medicinal chemistry
  • 1999
    • Corpus ID: 25441516
The antibacterial 4H-4-oxoquinolizines were introduced recently to overcome bacterial resistance to fluoroquinolones. They… Expand
Highly Cited
1996
Highly Cited
1996
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
Two novel series of 2-pyridones were synthesized by transposition of the nitrogen of 4-quinolones to the bridgehead position… Expand
1996
1996
Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.
ABT-719 is a 2-pyridone antimicrobial which inhibits DNA gyrase activity. It has considerable subcutaneous (sc) and oral efficacy… Expand
1995
1995
In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.
ABT-719 (A-86719.1) is the first compound of a new class of novel DNA gyrase inhibitors, the 2-pyridones, with potent… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
1995
1995
Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections.
The 2-pyridones are a new class of broad-spectrum orally bioavailable antibacterial agents. These compounds are potent bacterial… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE